Gateways To Make Pharmaceutical Patenting Attractive
Introduction The long-standing debate about patenting pharmaceutical products is akin to opening ‘Pandora’s box’ or like the malaise spread associated with health crises like HIV […]
pharmaceutical
ANOTHER WIN FOR NOVARTIS
Novartis has constantly been a party to patent battles. Some won, some lost. The landmark judgment in 2019 by the hon’ble apex court in Novartis […]
Short course: Pharmaceuticals and Intellectual Property by British Institute of International and Comparative Law (BIICL)
10 Sessions: 4 March – 13 May 2022 This is a wide-ranging course offering diverse legal and interdisciplinary perspectives exploring the nexus between global public […]
Public health lawfully outlaws the patent rights: a story of March-in rights!
My previous posts on the open-source innovation read with Doha style compulsory licensing and revocation in the public interest were exhaustive on the access to […]